Acid–base crystalline complexes and the pKa rule

Differences in the predicted aqueous pKa values (ΔpKa) have been calculated for 6465 crystalline complexes containing ionised and non-ionised acid–base pairs in the Cambridge Structural Database. A linear relationship between ΔpKa and the probability of proton transfer between acid–base pairs has been derived for crystalline complexes with ΔpKa between −1 and 4. The pKa rule is validated and quantitated.

[1]  William Jones,et al.  Pharmaceutical Cocrystallization: Engineering a Remedy for Caffeine Hydration , 2005 .

[2]  Naír Rodríguez-Hornedo,et al.  Solubility Advantage of Pharmaceutical Cocrystals , 2009 .

[3]  Aeri Park,et al.  The salt-cocrystal continuum: the influence of crystal structure on ionization state. , 2007, Molecular pharmaceutics.

[4]  Gargi Mukherjee,et al.  Polymorphs, Salts, and Cocrystals: What’s in a Name? , 2012 .

[5]  Donald C. Monkhouse,et al.  Review ArticlePharmaceutical Salts , 1977 .

[6]  A. Newman,et al.  Pharmaceutical Cocrystals and Their Physicochemical Properties , 2009, Crystal growth & design.

[7]  Jennifer B Dressman,et al.  Trends in active pharmaceutical ingredient salt selection based on analysis of the Orange Book database. , 2007, Journal of medicinal chemistry.

[8]  F. Allen.  The Cambridge Structural Database: a quarter of a million crystal structures and rising. , 2002, Acta crystallographica. Section B, Structural science.

[9]  W. Tong,et al.  In situ salt screening--a useful technique for discovery support and preformulation studies. , 1998, Pharmaceutical development and technology.

[10]  Robin Taylor,et al.  New software for searching the Cambridge Structural Database and visualizing crystal structures. , 2002, Acta crystallographica. Section B, Structural science.

[11]  Christer B Aakeröy,et al.  Cocrystal or salt: does it really matter? , 2007, Molecular pharmaceutics.

[12]  Abu T M Serajuddin,et al.  Salt formation to improve drug solubility. , 2007, Advanced drug delivery reviews.

[13]  Ning Shan,et al.  The role of cocrystals in pharmaceutical science. , 2008, Drug discovery today.

[14]  K. Aidas,et al.  Proton transfer in hydrogen-bonded pyridine/acid systems: the role of higher aggregation. , 2007, Physical chemistry chemical physics : PCCP.

[15]  S. L. Johnson,et al.  Infrared Spectra of Solid 1:1 Pyridine-Benzoic Acid Complexes; the Nature of the Hydrogen Bond as a Function of the Acid-Base Levels in the Complex1 , 1965 .

[16]  Peddy Vishweshwar,et al.  Pharmaceutical co-crystals. , 2006, Journal of pharmaceutical sciences.

[17]  William Jones,et al.  Occurrence of pharmaceutically acceptable anions and cations in the Cambridge Structural Database. , 2005, Journal of pharmaceutical sciences.

[18]  A. Nangia,et al.  Tape and layer structures in cocrystals of some di- and tricarboxylic acids with 4,4′-bipyridines and isonicotinamide. From binary to ternary cocrystals , 2005 .

[19]  Ron J Roberts,et al.  Structure, solubility, screening, and synthesis of molecular salts. , 2007, Journal of pharmaceutical sciences.